Table 1 Clinical characteristics of 106 patients with NPC
From: Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways
Characteristics | No. (%) |
|---|---|
Age, years | Â |
Median | 49 |
Range | 22-73 |
Gender | Â |
Male | 84 (79.2) |
Female | 22 (20.8) |
Tumor (T) stage | Â |
T1 | 24 (22.6) |
T2 | 33 (31.1) |
T3 | 33 (31.1) |
T4 | 16 (15.1) |
Lymphoid Nodal (N) status | Â |
N0 | 18 (17.0) |
N1 | 46 (43.4) |
N2 | 36 (29.2) |
N3 | 11 (10.4) |
Distant metastasis (M) status | Â |
M0 | 101 (95.3) |
M1 | 5 (4.7) |
TNM stage | Â |
I | 6 (5.7) |
II | 32 (30.2) |
III | 39 (36.8) |
IVa+IVb | 29 (27.4) |
Progression | Â |
No | 69 (65.1) |
Yes | 37 (34.9) |
Death | Â |
No | 76 (71.7) |
Yes | 30 (28.3) |
Histological type* | Â |
Type I | 1 (0.9) |
Type II | 13 (12.3) |
Type III | 92 (86.8) |
LMP1 | Â |
Positive | 47 (44.3) |
Negative | 56 (52.8) |
Missing | 3(2.8) |